1,5-Dihydro-benzo[e][1,4]oxazepin-2(1H)-ones containing a 7-(5′-cyanopyrrol-2-yl) group as nonsteroidal progesterone receptor modulators
Authors:
- Eugene A. TerefenkoETEugene A. Terefenko
- Andrew FensomeAFAndrew Fensome
- Ray UnwallaRURay Unwalla
- Jay WrobelJWJay Wrobel
- Jeffrey CohenJCJeffrey Cohen
- Yuan ZhuYZYuan Zhu
- Thomas J. BerrodinTBThomas J. Berrodin
- Matthew R. YudtMYMatthew R. Yudt
- Richard C. WinnekerRWRichard C. Winneker
- Zhiming ZhangZZZhiming Zhang
- Puwen ZhangPZPuwen Zhang
- 1 September 2008
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (18) , 5015-5017
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- 7-Aryl 1,5-dihydro-benzo[e][1,4]oxazepin-2-ones and analogs as non-steroidal progesterone receptor antagonistsBioorganic & Medicinal Chemistry, 2008
- Design, Synthesis, and SAR of New Pyrrole-Oxindole Progesterone Receptor Modulators Leading to 5-(7-Fluoro-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile (WAY-255348)Journal of Medicinal Chemistry, 2008
- SAR studies of 6-aryl-1,3-dihydrobenzimidazol-2-ones as progesterone receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2005
- Synthesis and Structure−Activity Relationship of Novel 6-Aryl-1,4- dihydrobenzo[d][1,3]oxazine-2-thiones as Progesterone Receptor Modulators Leading to the Potent and Selective Nonsteroidal Progesterone Receptor Agonist TanaprogetJournal of Medicinal Chemistry, 2005
- Novel pyrrole-containing progesterone receptor modulatorsBioorganic & Medicinal Chemistry Letters, 2004
- 6-Aryl-1,4-dihydro-benzo[d][1,3]oxazin- 2-ones: A Novel Class of Potent, Selective, and Orally Active Nonsteroidal Progesterone Receptor AntagonistsJournal of Medicinal Chemistry, 2002
- Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486)American Journal of Obstetrics and Gynecology, 1998
- The nuclear receptor superfamily: The second decadeCell, 1995
- Clinical efficacy of the antiprogesterone RU486 in the treatment of endometriosis and uterine fibroidsHuman Reproduction, 1994
- GAL4 fusion vectors for expression in yeast or mammalian cellsGene, 1992